There is a need for individualised requirements for the optimal treatment of hypothyroidism. There is no ‘one size fits all’ in both treatment and necessary lab values and patient symptoms need to highly in focus.
The paper highlights that:
- The TSH measure alone is really not sensitive enough to tell a doctor when a patient is properly treated.
- Everyone has their own individual needs and set-points for levels – there is no one size fits for thyroid levels and lab results for all patients.
- Being somewhere in the lab range for FT4 and FT3 does not mean the patient is correctly treated.
- T4 leaves many feeling unwell.
- T3 often needs to be in the treatment, as many conditions and thyroid tissue loss leaves patients low in the conversion of T4 to T3.
- Many issues get in the way of conversion including loss of thyroid tissue, deiodinase defects, etc.
- Patient symptoms need to be at the forefront of treatment – not placed after lab results which only include TSH and FT4.
- There need to be other biochemical markers of being adequately treated – TSH, FT4, and FT3 are not enough.
Here is the link to the new paper by Hoermann, Midgley, Larisch and Dietrich:
“Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options”
Hoermann, Midgley, Larisch and Dietrich.
Drugs in Context
(You can download the full paper from the link within the abstract)
However, I have uploaded it and you can see it by clicking here.